3rd Quarter - Report

MEHLMAN CONSULTING, INC. for AARP, INC.

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Part D Beneficiary out of pocket and cost sharing protections. HR 3 -- Lower Drug Costs Now Act of 2019

LobbyistCovered position, as disclosed
LAUREN ARONSON —
MCKENZIE BRICE —
DAVID CASTAGNETTI —
NICHOLE DISTEFANO —
SAGE EASTMAN —
ELISE FINLEY PICKERING —
STEVE HARO —
CONSTANTINE HINGSON —
BRUCE MEHLMAN —
MICHAEL ROBINSON —
DEAN ROSEN —
DAVID R THOMAS —
PAUL THORNELL New Deputy Director of Legislative Affairs, Office of Vice President Al Gore, The White House; Associate Director, Senate Democratic Steering Committee, Senator Tom Daschle
HELEN TOLAR —
CHARLES WOOTERS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3 (116th)

Pharmacy PHA

S.1895 - Lower Health Care Costs Act including issues relating to drug pricing included in S. 340 and H.R. 965 - The Creating and Restoring Equal Access To Equivalent Samples (CREATES) Act. S. 2543 - Prescription Drug Pricing Reduction Act of 2019. House prescription drug price transparency legislation.

LobbyistCovered position, as disclosed
LAUREN ARONSON —
MCKENZIE BRICE —
DAVID CASTAGNETTI —
NICHOLE DISTEFANO —
SAGE EASTMAN —
ELISE FINLEY PICKERING —
STEVE HARO —
CONSTANTINE HINGSON —
BRUCE MEHLMAN —
MICHAEL ROBINSON —
DEAN ROSEN —
DAVID R THOMAS —
PAUL THORNELL New Deputy Director of Legislative Affairs, Office of Vice President Al Gore, The White House; Associate Director, Senate Democratic Steering Committee, Senator Tom Daschle
HELEN TOLAR —
CHARLES WOOTERS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1895 (116th), S. 340 (116th), H.R. 965 (116th), S. 2543 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.